Z, U., Á, B., A, U., M, F., G, B., & B, G. (2025). Prognostic impact of glucagon-like peptide-1 receptor (GLP1R) expression on cancer survival and its implications for GLP-1R agonist therapy: An integrative analysis across multiple tumor types. GeroScience, 47(3), 4413. https://doi.org/10.1007/s11357-024-01494-5
Chicago Style (17th ed.) CitationZ, Ungvari, Bartha Á, Ungvari A, Fekete M, Bianchini G, and Győrffy B. "Prognostic Impact of Glucagon-like Peptide-1 Receptor (GLP1R) Expression on Cancer Survival and Its Implications for GLP-1R Agonist Therapy: An Integrative Analysis Across Multiple Tumor Types." GeroScience 47, no. 3 (2025): 4413. https://doi.org/10.1007/s11357-024-01494-5.
MLA (9th ed.) CitationZ, Ungvari, et al. "Prognostic Impact of Glucagon-like Peptide-1 Receptor (GLP1R) Expression on Cancer Survival and Its Implications for GLP-1R Agonist Therapy: An Integrative Analysis Across Multiple Tumor Types." GeroScience, vol. 47, no. 3, 2025, p. 4413, https://doi.org/10.1007/s11357-024-01494-5.